Boston GlobeVertex Pharma's combination cystic fibrosis therapy wins FDA nodReutersJuly 2 Vertex Pharmaceuticals Inc's combination therapy for a rare lung disorder was approved by U.S. health regulators, extending the company's reach to now treat the most common form of genetic mutation responsible for cystic fibrosis. Orkambi ...FDA approves Vertex's treatment for cystic fibrosisBoston GlobeFDA clears drug for leading form of cystic fibrosisWashington TimesVertex wins a crucial FDA nod for its cystic fibrosis comboFierceBiotechBoston Business Journal (blog) -WallStreet Scope -The Legacyall 7 news articles »
:)
:(
=(
^_^
:D
=D
|o|
@@,
;)
:-bd
:-d
:p
